Press Release / Media Release
Zydus receives final approval from the USFDA for Mycophenolate Mofetil for Injection USP02-09-2017
02-09-2017
Zydus Cadila gets USFDA nod to market anti-dementia drug
Group now has around 140 approvals and has so far filed over 300 abbreviated new drug applications01-09-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Donepezil Hydrochloride Tablets.01-09-2017
Zydus Cadila gets USFDA nod for blood clotting drug, shares up over 2%
Zydus Cadila has received approval from the US health regulator to market aspirin and extended release dipyridamole capsules, used to prevent excessive blood clotting and reduce the risk of strokes.30-08-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Aspirin and Extended-Release Dipyridamole Capsules30-08-2017
Press Release / Media Release
Zydus receives EIR Report for Manufacturing Facility at the Pharma SEZ at Ahmedabad29-08-2017
US sales give Cadila Healthcare an edge over peers
Faster product-approval rate leads to higher earnings growth visibility24-08-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Candesartan Cilexetil Tablets.24-08-2017
Zydus gets USFDA nod for manic depression drug
Cadila Healthcare Ltd (Zydus Cadila), on Wednesday, said it has received final approval from the USFDA to market Ziprasidone Hydrochloride capsules in the American market. The drug, in strengths...23-08-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Ziprasidone Hydrochloride Capsules.23-08-2017